Sign in
  • R&D
  • Clinical
  • Commercial
    • Brand & Marketing
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
LogoLifeNewsLife Science
LogoFashion Trends and Culture
  • R&D
    • Research & Development

      Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

      April 10, 2026
      Research & Development

      Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

      April 1, 2026
      Research & Development

      Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

      November 7, 2025
      Research & Development

      Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

      August 31, 2025
  • Clinical
    • Clinical

      Stipple Bio Secures $100 Million Series A to Advance STP-100 Toward Clinical Trials

      April 7, 2026
      Clinical

      Alto Neurosciences Discontinues ALTO-101 After Phase 2 Trial Fails to Meet Primary Endpoint

      April 3, 2026
      Clinical

      AstraZeneca Scores Win as Imfinzi, Imjudo Delay Liver Cancer Progression

      April 3, 2026
      Clinical

      Immunovant’s Batoclimab Fails to Meet Primary Endpoints in Two Phase 3 Thyroid Eye Disease Trials

      April 3, 2026
  • Commercial
    • AllBrand & Marketing
      Commercial

      Roche Wagers $20M on C4T’s Antibody-Focused Protein Degraders

      April 10, 2026
      Commercial

      Neurocrine Makes Huge M&A Deal With Nearly $3B Soleno Buyout

      April 7, 2026
      Commercial

      KBP Biosciences Makes Effort to Bring Troubled Heart Drug Back to Life

      April 4, 2026
  • Technology
    • Technology

      Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

      July 7, 2025
      Technology

      J&J MedTech presents the first Ottava surgical robot clinical cases

      April 17, 2025
      Commercial

      Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

      October 23, 2024
      Technology

      PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

      September 26, 2024
  • Insights
    • Insights

      The Rise of Value-Based Pricing in Life Sciences

      April 10, 2026
      Insights

      Balancing Innovation and Compliance in a Changing Regulatory Environment

      April 7, 2026
      Insights

      How Is Regulatory Harmonization Impacting Global Pharma Companies?

      April 4, 2026
      Insights

      The Growing Role of Real-World Evidence in Regulatory Decision-Making

      April 4, 2026
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial
type here...
Facebook
Linkedin
Twitter
Home Tags Agenus

Tag: Agenus

Bristol-Myers Squibb and Agenus enter a $1.56bn definitive agreement to support cancer programme
Featured

Bristol-Myers Squibb and Agenus enter a $1.56bn definitive agreement to support cancer programme

Editorial Team -
May 29, 2021
0

Editor Picks

Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

August 31, 2025

NextCure Signs $745 Million Licensing Agreement for SIM0505 with Simcere Zaiming

June 17, 2025

Breyanzi Receives FDA Approval for Marginal Zone Lymphoma

December 15, 2025

Must Read

Roche Wagers $20M on C4T’s Antibody-Focused Protein Degraders

April 10, 2026

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

April 10, 2026

The Rise of Value-Based Pricing in Life Sciences

April 10, 2026

Hot Topics

  • Clinical410
  • Commercial384
  • Regulatory317
  • Research & Development104
  • Manufacturing82
  • Newsletter59
  • Insights53
  • Technology40
Logo

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

Facebook
Instagram
Linkedin
Twitter

© Copyright - Life Sciences Voice

  • R&D
  • Clinical
  • Commercial
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Winners
    • LSV Rising Stars Award 2025 Winner List
  • More
    • Manufacturing
    • Regulatory
    • Editorial